HU1000527D0 - Process for preparing 21-chloro-corticosteroids - Google Patents

Process for preparing 21-chloro-corticosteroids

Info

Publication number
HU1000527D0
HU1000527D0 HU1000527A HU1000527A HU1000527D0 HU 1000527 D0 HU1000527 D0 HU 1000527D0 HU 1000527 A HU1000527 A HU 1000527A HU 1000527 A HU1000527 A HU 1000527A HU 1000527 D0 HU1000527 D0 HU 1000527D0
Authority
HU
Hungary
Prior art keywords
steroids
chloro
delta
beta
corticosteroids
Prior art date
Application number
HU1000527A
Other languages
English (en)
Other versions
HU227379B1 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HU1000527D0 publication Critical patent/HU1000527D0/hu
Publication of HU227379B1 publication Critical patent/HU227379B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HU1000527A 1994-06-01 1995-05-30 Process for preparing 21-chloro-corticosteroids HU227379B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/252,302 US5502222A (en) 1994-06-01 1994-06-01 Process for preparing delta 9,11 and 21-chloro corticosteroids

Publications (2)

Publication Number Publication Date
HU1000527D0 true HU1000527D0 (en) 2010-11-29
HU227379B1 HU227379B1 (en) 2011-05-30

Family

ID=22955451

Family Applications (3)

Application Number Title Priority Date Filing Date
HU9603299A HU227380B1 (en) 1994-06-01 1995-05-30 Process for preparing delta 9,11 and 21-chloro corticosteroids
HU0302654A HU227378B1 (en) 1994-06-01 1995-05-30 Process for preparing delta 9,11 -chloro corticosteroids
HU1000527A HU227379B1 (en) 1994-06-01 1995-05-30 Process for preparing 21-chloro-corticosteroids

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HU9603299A HU227380B1 (en) 1994-06-01 1995-05-30 Process for preparing delta 9,11 and 21-chloro corticosteroids
HU0302654A HU227378B1 (en) 1994-06-01 1995-05-30 Process for preparing delta 9,11 -chloro corticosteroids

Country Status (18)

Country Link
US (3) US5502222A (hu)
EP (3) EP0763054B1 (hu)
JP (1) JP2831472B2 (hu)
KR (4) KR100226568B1 (hu)
AT (3) ATE188481T1 (hu)
AU (1) AU696425B2 (hu)
CA (1) CA2191324C (hu)
DE (3) DE69535756D1 (hu)
DK (1) DK0063054T3 (hu)
ES (3) ES2306487T3 (hu)
FI (3) FI118801B (hu)
GR (1) GR3032714T3 (hu)
HU (3) HU227380B1 (hu)
IL (5) IL113918A (hu)
MX (1) MX9605893A (hu)
NZ (1) NZ287348A (hu)
PT (1) PT763054E (hu)
WO (1) WO1995032989A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
DE69637140T2 (de) 1995-12-11 2008-04-10 G.D. Searle Llc, Chicago Verfahren zur herstellung einer epoxy-verbindung
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
DE69716116T2 (de) 1996-12-11 2003-09-04 Searle & Co VERFAHREN ZUR HERSTELLUNG VON 3-KETO-7alpha-ALKOXYCARBONYL- delta4,5-STEROIDEN SOWIE ZWISCHENPRODUKTE
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
EP1490390A2 (en) * 2002-03-22 2004-12-29 Pharmacia Corporation C-17 spirolactonization and 6,7 oxidation of steroids
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
MX2009006228A (es) 2006-12-12 2009-06-22 Schering Corp Inhibidores de aspartil proteasa.
LT2805720T (lt) 2008-05-28 2019-09-25 Reveragen Biopharma, Inc. Nehormoniniai steroidiniai nf-kb moduliatoriai, skirti ligoms gydyti
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107840865A (zh) * 2016-09-20 2018-03-27 天津金耀集团有限公司 一种甲泼尼龙的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US10953257B2 (en) 2019-04-19 2021-03-23 Kidde Technologies, Inc. Fire suppression composition
US11326998B2 (en) 2019-04-19 2022-05-10 Kidde Technologies, Inc. System and method for monitoring a fire suppression blend
EP4134373A1 (en) 2021-08-12 2023-02-15 Santhera Pharmaceuticals (Schweiz) AG Synthesis of delta 9,11 steroids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28369E (en) * 1957-02-27 1975-03-18 Atcc-zxs
US3947409A (en) * 1958-06-19 1976-03-30 Merck & Co., Inc. 16-Alkyl-1,4,9(11)-pregnatrienes and 9,11-epoxides thereof
DE1127895B (de) * 1958-12-24 1962-04-19 Ciba Geigy Verfahren zur Herstellung von reinen 9 (11)-ungesaettigten Steroiden
US3284477A (en) * 1963-07-10 1966-11-08 Schering Corp Diuretic 1, 4, 9(11)-pregnatrienes
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
US3933799A (en) * 1969-01-29 1976-01-20 Glaxo Laboratories Limited 11β-Halo-9,12-unsubstituted-C19 -steroids
GB1504133A (en) * 1975-02-24 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
GB1504134A (en) * 1975-02-25 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
BG33737A3 (en) * 1978-01-25 1983-04-15 Schering Ag,De Method for obtaining of substituated in 17- th position steroids from pregnan row
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3640709A1 (de) * 1986-11-28 1988-06-09 Schering Ag Verfahren zur herstellung von 6(alpha),9(alpha)-difluor-11ss,17(alpha)-dihydroxy-16(alpha)-methyl-4-pregnen-3,20-dion und dessen derivate
US4920216A (en) * 1987-05-28 1990-04-24 The Trustees Of Columbia In The City Of New York Selective chlorination of steroids and other substrates directed by covalently linked pyridine derivatives acting as templates
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids

Also Published As

Publication number Publication date
CA2191324A1 (en) 1995-12-07
JP2831472B2 (ja) 1998-12-02
US5750745A (en) 1998-05-12
WO1995032989A1 (en) 1995-12-07
US5502222A (en) 1996-03-26
DE69514352D1 (de) 2000-02-10
IL126598A (en) 2003-07-31
CA2191324C (en) 2001-08-28
MX9605893A (es) 1997-12-31
JPH09506113A (ja) 1997-06-17
EP0763054A1 (en) 1997-03-19
FI20050181A (fi) 2005-02-16
EP0969011A2 (en) 2000-01-05
ATE397008T1 (de) 2008-06-15
IL126598A0 (en) 1999-08-17
FI117600B (fi) 2006-12-15
US5616742A (en) 1997-04-01
ES2306487T3 (es) 2008-11-01
AU2603595A (en) 1995-12-21
HU227378B1 (en) 2011-05-30
EP0763054B1 (en) 2000-01-05
NZ287348A (en) 1998-12-23
HU0302654D0 (en) 2003-10-28
GR3032714T3 (en) 2000-06-30
EP0969012A3 (en) 2004-10-06
PT763054E (pt) 2000-06-30
DE69535756D1 (de) 2008-06-26
AU696425B2 (en) 1998-09-10
IL126597A0 (en) 1999-08-17
EP0969011B1 (en) 2008-05-28
FI117599B (fi) 2006-12-15
KR100290226B1 (ko) 2001-05-15
EP0969012A2 (en) 2000-01-05
DE69514352T2 (de) 2000-08-24
HU227380B1 (en) 2011-05-30
FI964739A (fi) 1996-11-28
IL113918A0 (en) 1995-08-31
HU227379B1 (en) 2011-05-30
DK0063054T3 (da) 2000-06-19
IL113918A (en) 1999-12-31
KR100290227B1 (ko) 2001-05-15
KR100290225B1 (ko) 2001-05-15
ES2306488T3 (es) 2008-11-01
EP0969012B1 (en) 2008-05-14
FI118801B (fi) 2008-03-31
FI20050180A (fi) 2005-02-16
ATE188481T1 (de) 2000-01-15
EP0969011A3 (en) 2004-10-06
ES2140678T3 (es) 2000-03-01
HU9603299D0 (en) 1997-01-28
FI964739A0 (fi) 1996-11-28
DE69535765D1 (de) 2008-07-10
HUT75518A (en) 1997-05-28
KR100226568B1 (ko) 1999-10-15
IL126597A (en) 2003-09-17
ATE395353T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
FI20050181A (fi) Menetelmä valmistaa 21-kloorikortikosteroideja
IE872476L (en) Modified ceramic structures and methods of making the same
HUT64770A (en) New method for producing 11-keto-steroide derivatives
EP0231950A3 (en) Method of nonlinear a/d conversion
ES476631A1 (es) Un procedimiento para obtener cristales de maltosa.
ES8800262A1 (es) Procedimiento de preparacion de 21-hidroxi-20-ceto-delta16-esteroides
IE821109L (en) Fermentation
Perdrix et al. Mechanical Behavior and structure development of aluminum during Hot deformation With large Amplitude
PFUFF Representation of cracks by dislocations and its application to the fracture toughness of metals
JPS57193498A (en) Preparation of 2-bromo-6beta,9alpha-difluoro-11beta,17alpha,21-trihydroxy- 1,4-pregnadiene-3,20-dione-17,21-diesters
Danilenko et al. Reconstruction of a 250(10 in.) Rod Mill to Produce High Duty Rod
WO1990015067A3 (fr) NOUVEAUX PROCEDES D'OBTENTION DE 6-METHYL 19-NOR STEROIDES ET LEUR CONVERSION EN 19-NOR PREGNADIENES 17α-SUBSTITUES
ES478942A1 (es) Un procedimiento para la conversion selectica de 20-metil- pregna-3,5,20(21)-trino-3,2-diol-diacetato en 3-oxo-metil- pregna-4,20(21)-dieno-21-il-acetato.
Grozdanova A Method for the Optimum Synthesis of Aggregate Machine Tools Structure
Wood et al. Some aspects of the low temperature deformation behaviour of Type 316 steel
BRUSIN A problem of adaptive adjustment of continuous controlled plants
HU9503063D0 (en) New 16-(substituted methyl)-pregna-1,4-diene-3,20-dione derivatives and process for producing them
JPS5529272A (en) Cyclo converter
PL263783A1 (en) Method of obtaining 6-alpha-fluoro-16-alpha,17-alpha-isopropylidenedioxy-11-betha,21-dihydroxy-4-pregnene-3,20-dione
JPS53107633A (en) Controller for dc power transmission system

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees